Christopher Macomber, MD, MBA

Dr. Macomber is a general surgeon and medical technology entrepreneur with a background in medical device development and health information technology.  He is the Founder and Chief Medical Officer of UV Therapeutics, a med tech company developing a device based approach for system immune modulation and is currently conducting it’s first human clinical trial for the treatment of Lupus.

Chris recently co-founded a mobile EMR integration platform for providers, Mozaic Medical, that will be launching it’s first platform in 2015.  He is the co-founder and assistant director of the Surgical Technology Innovation and Commercialization program at UMass (STIC-UM) and co-founder of the Institute for Inflammatory Disease (INSIDE) at the University Hospitals Coventry and Warwickshire NHS Trust.  He also performs medical technology consulting for industry companies.

Chris received a Bachelors of Science in Biology and Music from Union College in 2005, an MBA in Health Care Management from the Graduate College of Union University in 2006 and an MD with Distinction in Health Management Systems from Albany Medical College in 2009, as part of the Eight-Year Leadership in Medicine BS/MBA/MD program.  He also completed a two-year research fellowship in surgical outcomes and surgical technology innovation and attended the Program in Clinical Effectiveness at the Harvard School of Public Health in 2011.  Concurrently with his role at UVT, Chris is completing his last year of general and laparoscopic surgery as Chief Resident at the University of Massachusetts Medical School.  He is a member of the Alpha Omega Alpha Honor Medical Society and the Gold Humanism Honor Society.

Need more info?
Send us a message